Gilead Shareholders Awarded $1.8 Million for Attorneys’ Fees and Expenses In Delaware Section 220 Trial

n November 2020, Pomerantz received a ruling in a Section 220 books and records proceeding that included a startling admonition from the Delaware Court of Chancery criticizing the overly aggressive defense strategy adopted by Gilead Sciences, Inc. At the time, the Court opened the door for fee shifting in the case: “Defendants like Gilead adopt this strategy with the apparent belief that there is no real downside to doing so…”